Woodline Partners LP Gilead Sciences, Inc. Transaction History

Woodline Partners LP

$9.97 Billion
Q2 2024

A detailed history of Woodline Partners LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 1,006,492 shares of GILD stock, worth $83.6 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

1,006,492

Previous 1,000,779 0.57%

Holding current value

$83.6 Million

Previous $73.3 Million 5.8%

% of portfolio

0.69%

Previous 0.7%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $360,775 - $416,363	5,713 Added 0.57%	1,006,492 $69.1 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $33.2 Million - $40.4 Million	-463,362 Reduced 31.65%	1,000,779 $73.3 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $55.9 Million - $63.4 Million	763,205 Added 108.88%	1,464,141 $119 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $3.16 Million - $3.45 Million	42,736 Added 6.49%	700,936 $52.5 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $15.8 Million - $18.1 Million	208,421 Added 46.34%	658,200 $50.7 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $3.55 Million - $4.05 Million	45,946 Added 11.38%	449,779 $37.3 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $116 Million - $166 Million	-1,858,858 Reduced 82.15%	403,833 $34.7 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $110 Million - $125 Million	1,844,728 Added 441.36%	2,262,691 $140 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $216,103 - $243,397	-3,744 Reduced 0.89%	417,963 $25.8 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $13.2 Million - $16.6 Million	-228,381 Reduced 35.13%	421,707 $25.1 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $27.9 Million - $31.7 Million	-430,079 Reduced 39.82%	650,088 $47.2 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $29.3 Million - $32 Million	-461,726 Reduced 29.95%	1,080,167 $74.4 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $92.5 Million - $106 Million	1,541,893 New	1,541,893 $99.7 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $9.54 Million - $12 Million	-153,614 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $11.1 Million - $12.9 Million	153,614 New	153,614 $11.8 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $53.1 Million - $68 Million	-847,869 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $52.2 Million - $57.5 Million	847,869 New	847,869 $55.1 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $104B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Gilead Sciences, Inc. Transaction History